Breaking News

Piramal Pharma’s GHG Emission Reduction Targets Validated by SBTi

Reinforces its ongoing commitment to reducing its GHG emissions and aligning with global climate action goals.

Author Image

By: Charlie Sternberg

Associate Editor

The Science Based Targets Initiative (SBTi) has officially validated Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets. This validation aligns with Piramal Pharma’s core purpose of “Doing Well and Doing Good,” driving its business strategies and strengthening its commitment to making consistent, measurable progress toward a more sustainable future.   Piramal Pharma has committed to reducing absolute scope 1 and 2 GHG emissions by 42% by FY2030 from a FY2022 base ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters